Clinical Trial Update: Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating the combination of linperlisib with chidamide for relapsed or refractory peripheral T-cell lymphoma; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Linperlisib (linperlisib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Peripheral T Cells Lymphoma (PTCL) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING